NCT00430885View on ClinicalTrials.gov

Effect of Intravenous Immunglobulin (IVIG) After Myocardial Infarction

PHASE3CompletedINTERVENTIONAL
Enrollment

62

Participants

Timeline

Start Date

February 28, 2007

Primary Completion Date

May 31, 2009

Study Completion Date

May 31, 2010

Conditions
Acute Myocardial Infarction
Interventions
DRUG

Octagam (IVIG)

Intravenous immunoglobulin 0.4 g/kg given as infusion

Trial Locations (1)

Unknown

Rikshospitalet University Hospital, Oslo

All Listed Sponsors
collaborator

Helse Stavanger HF

OTHER_GOV

lead

Oslo University Hospital

OTHER

NCT00430885 - Effect of Intravenous Immunglobulin (IVIG) After Myocardial Infarction | Biotech Hunter | Biotech Hunter